Roxane Asks Fed. Circ. To Halt Hetero's Generic Kidney Drug

French pharmaceutical giant Sanofi-Aventis US Inc. sued Merck & Co. Inc.'s overseas unit in Delaware federal court , alleging the rival pharmaceutical company developed a diabetes drug that infringes 10 patents for its top-selling Lantus insulin product and its SoloStar injection pen.

The suit alleges Merck Sharp & Dohme Corp. intentionally developed its new insulin drug, MK-1293, using Sanofi’s patented products in order to harm Sanofi’s Lantus sales. It seeks a permanent injunction barring Merck from developing drugs that infringe Sanofi patents


Rate this item
(0 votes)
Login to post comments

Newsletter Subscription

Joomla forms builder by JoomlaShine

IP2017 Banner 380x280

IP Era 300x250

Go to top